[ad_1]
Pfizer vaccine [사진=로이터 연합뉴스]
On the 12th (local time), the Vaccination Advisory Committee (ACIP), an advisory body to the Centers for Disease Control and Prevention (CDC), recommended the use of Pfizer’s COVID-19 (novel coronavirus infection) vaccine. . It is evaluated that it has crossed the definitive gateway to the distribution of vaccines in the United States.
The ACIP held a meeting and voted to recommend that Americans age 16 and older inject the COVID-19 vaccine jointly developed by Pfizer and Bioentech, Bloomberg News and CNN reported.
The ACIP voted ’11 to 0 ‘and decided that the vaccine was appropriate for the general public in the United States. Three of the advisers abstained from voting due to a conflict of interest.
The ACIP also recommended that people who have had hypersensitivity or allergic reactions be monitored by a doctor or nurse for 30 minutes after vaccination. It is recommended that pregnant women, breastfeeding women, and people with immune system problems decide whether to vaccinate themselves.
“We voted in favor of this vaccine because of the clear evidence in the efficacy and safety registry, as well as its benefits and risks,” said Peter Silage, a professor of pediatrics at the University of California, Los Angeles, one of its advisers. .
The ACIP vaccination recommendations are a process that must be followed in order for newly developed vaccines to be vaccinated in people. If CDC Director Robert Redfield accepts this recommendation and officially approves the use of the vaccine, then the vaccine can be injected into people’s arms.
CNN reported that Redfield is expected to approve the ACIP recommendations in a few hours.
Prior to this, another government agency, the United States Food and Drug Administration (FDA), the Vaccine and Biological Drug Advisory Committee (VRBPAC), recommended to the FDA the urgent use of Pfizer’s Corona 19 vaccine on the day 10.
According to the Associated Press, the advisory committee deliberated on the agenda for the urgent use of the Pfizer vaccine that day and made the decision to recommend approval by vote. The vote was confirmed by 17 votes in favor, 4 against and 1 abstention.
Meanwhile, on the 17th there will be a meeting of the FDA Advisory Committee to review the urgent use agenda of the vaccine applied by Modena. The advisory committee is expected to continue to review vaccines developed by Johnson & Johnson and AstraZeneca.
Reporter Kang Kyung-joo [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution
